This inventor holds 1 USPTO granted patent. Top assignee: Fred Hutchinson Cancer Center. Active years: 1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992
Title: The Innovations of Sen-itroh Hakomori
Introduction
Sen-itroh Hakomori is a notable inventor based in Mercer Island, Washington. He has made significant contributions to the field of cancer research through his innovative work on monoclonal antibodies. His research focuses on the detection and treatment of specific types of tumor cells.
Latest Patents
Hakomori holds a patent for hybridomas producing monoclonal antibodies that recognize glycolipids with mono-, di-, and trifucosylated type 2 chain structures. This patent describes hybridoma cell lines that produce monoclonal antibodies useful for diagnosing and treating human cancer. The antibodies can specifically detect tumor cells characterized by the presence of these unique glycolipid structures.
Career Highlights
Hakomori is affiliated with the Fred Hutchinson Cancer Center, where he conducts his research. His work has been instrumental in advancing the understanding of cancer biology and improving diagnostic methods. He has dedicated his career to developing innovative solutions for cancer detection and treatment.
Collaborations
Hakomori collaborates with Yasuo Fukushi, contributing to the advancement of research in their field. Their partnership enhances the potential for breakthroughs in cancer research and therapy.
Conclusion
Sen-itroh Hakomori's contributions to the field of cancer research through his innovative patents and collaborations highlight his commitment to improving cancer diagnosis and treatment. His work continues to impact the scientific community and offers hope for advancements in cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile